Drug
Rgb 14 P
Rgb 14 P: highest development phase Phase 3, developed by Gedeon Richter. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Gedeon Richter
Trials
| Drug | Phase | Indication |
|---|---|---|
| RGB-14-P NCT05087030 | Phase 3 | Postmenopausal Osteoporosis |
Latest
No recent events.
Follow Rgb 14 P on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.